Phreesia, Inc. (NYSE:PHR) Insider Janet Gunzburg Sells 2,768 Shares

→ READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad)

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Janet Gunzburg sold 2,768 shares of Phreesia stock in a transaction that occurred on Wednesday, April 10th. The shares were sold at an average price of $23.10, for a total value of $63,940.80. Following the completion of the transaction, the insider now owns 36,132 shares in the company, valued at $834,649.20. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Janet Gunzburg also recently made the following trade(s):

  • On Monday, April 8th, Janet Gunzburg sold 1,709 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $38,657.58.
  • On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The shares were sold at an average price of $23.27, for a total value of $65,551.59.
  • On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $13,440.00.
  • On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The shares were sold at an average price of $25.99, for a total value of $8,524.72.

Phreesia Stock Performance

Shares of NYSE PHR traded down $0.20 during trading on Friday, reaching $23.60. The company had a trading volume of 664,036 shares, compared to its average volume of 525,693. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $34.98. The stock has a 50-day moving average price of $24.76 and a two-hundred day moving average price of $21.09. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78.


Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.58) by $0.02. The business had revenue of $95.00 million during the quarter, compared to the consensus estimate of $93.52 million. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The business's revenue for the quarter was up 24.0% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.72) earnings per share. Research analysts expect that Phreesia, Inc. will post -1.48 EPS for the current year.

Institutional Investors Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Acadian Asset Management LLC purchased a new stake in Phreesia during the first quarter valued at about $43,000. Captrust Financial Advisors grew its position in Phreesia by 154.6% during the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company's stock valued at $36,000 after acquiring an additional 866 shares during the period. International Assets Investment Management LLC grew its position in Phreesia by 1,987.3% during the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company's stock valued at $34,000 after acquiring an additional 1,411 shares during the period. State of Wyoming grew its position in Phreesia by 34.6% during the second quarter. State of Wyoming now owns 1,918 shares of the company's stock valued at $59,000 after acquiring an additional 493 shares during the period. Finally, Tower Research Capital LLC TRC grew its position in Phreesia by 85.4% during the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company's stock valued at $80,000 after acquiring an additional 1,445 shares during the period. Hedge funds and other institutional investors own 92.10% of the company's stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. DA Davidson reiterated a "neutral" rating and issued a $32.00 target price on shares of Phreesia in a research note on Friday, March 15th. Raymond James reissued an "outperform" rating and issued a $30.00 price target (up from $25.00) on shares of Phreesia in a report on Friday, March 15th. Royal Bank of Canada reissued a "sector perform" rating and issued a $23.00 price target on shares of Phreesia in a report on Thursday, March 21st. Canaccord Genuity Group raised their price target on Phreesia from $36.00 to $37.00 and gave the company a "buy" rating in a report on Friday, March 15th. Finally, JMP Securities raised their price target on Phreesia from $28.00 to $30.00 and gave the company a "market outperform" rating in a report on Thursday, March 21st. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $31.62.

Check Out Our Latest Stock Report on PHR

About Phreesia

(Get Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Featured Articles

Insider Buying and Selling by Quarter for Phreesia (NYSE:PHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Phreesia right now?

Before you consider Phreesia, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.

While Phreesia currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Featured Articles and Offers

Search Headlines: